Ameriprise Portfolio holdings
Ameriprise Financial, Inc., founded in 1894 as Investors Syndicate and headquartered in Minneapolis, Minnesota, is a leading financial services firm specializing in wealth management, financial planning, and insurance, managing hundreds of billions in assets for individual and institutional clients. Evolving from its roots in investment certificates, it now offers a comprehensive suite of services, including retirement planning, annuities, mutual funds, and advisory solutions, delivered through a network of over 10,000 financial advisors across the U.S. Known for its client-first approach, Ameriprise became independent in 2005 after spinning off from American Express, focusing on personalized advice and robust digital tools to compete in a crowded market. With a strong emphasis on long-term relationships and financial security, Ameriprise has grown into a trusted name in the retail investment and insurance sectors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$601M |
| 2 |
Gilead Sciences
GILD
|
+$574M |
| 3 |
NVIDIA
NVDA
|
+$429M |
| 4 |
Altria Group
MO
|
+$370M |
| 5 |
WIX.com
WIX
|
+$294M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$581M |
| 2 |
eBay
EBAY
|
+$465M |
| 3 |
Lam Research
LRCX
|
+$300M |
| 4 |
Becton Dickinson
BDX
|
+$267M |
| 5 |
UnitedHealth
UNH
|
+$265M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Financials | 11.82% |
| 3 | Industrials | 8.17% |
| 4 | Healthcare | 7.52% |
| 5 | Consumer Discretionary | 7.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Anavex Life Sciences
AVXL
$310M
| $793K | ﹤0.01% |
85,990
+1,233
| +1% | +$10.5K |
|
3302
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.51B
| $785K | ﹤0.01% |
6,243
-2,704
| -30% | -$324K |
|
3303
State Street SPDR Portfolio MSCI Global Stock Market ETF
SPGM
$1.78B
| $785K | ﹤0.01% |
11,381
+4,460
| +64% | +$286K |
|
|
HDSN
3304
Hudson Technologies
HDSN
$235M
| $783K | ﹤0.01% |
96,380
-29,711
| -24% | -$204K |
|
3305
B&G Foods
BGS
$286M
| $782K | ﹤0.01% |
184,452
-91,822
| -33% | -$480K |
|
|
NESR
3306
National Energy Services Reunited Corp
NESR
$2.93B
| $780K | ﹤0.01% |
129,600
| – | – |
|
3307
NRC Health Common Stock
NRC
$450M
| $780K | ﹤0.01% |
46,403
+9,599
| +26% | +$130K |
|
3308
Columbia India Consumer ETF
INCO
$239M
| $776K | ﹤0.01% |
11,959
-207
| -2% | -$13.1K |
|
3309
Janus Henderson B-BBB CLO ETF
JBBB
$1.41B
| $774K | ﹤0.01% |
16,052
-82
| -0.5% | -$3.94K |
|
3310
US Global Jets ETF
JETS
$800M
| $773K | ﹤0.01% |
33,649
-7,506
| -18% | -$159K |
|
3311
Tyra Biosciences
TYRA
$1.58B
| $771K | ﹤0.01% |
+80,602
| New | +$766K |
|
3312
Mizuho Financial
MFG
$130B
| $771K | ﹤0.01% |
138,728
-3,688
| -3% | -$19.1K |
|
3313
TaskUs
TASK
$669M
| $769K | ﹤0.01% |
45,903
-837,891
| -95% | -$12.8M |
|
3314
Enovix
ENVX
$1.03B
| $769K | ﹤0.01% |
85,014
-46,396
| -35% | -$303K |
|
3315
Dimensional International Value ETF
DFIV
$21.6B
| $764K | ﹤0.01% |
17,830
-991
| -5% | -$40.4K |
|
3316
Aveanna Healthcare
AVAH
$2.07B
| $763K | ﹤0.01% |
145,982
+91,508
| +168% | +$465K |
|
|
SRTA
3317
Strata Critical Medical Inc
SRTA
$512M
| $762K | ﹤0.01% |
189,111
| – | – |
|
3318
Morgan Stanley Direct Lending Fund
MSDL
$1.31B
| $761K | ﹤0.01% |
43,585
+1,021
| +2% | +$19.7K |
|
3319
RBB Bancorp
RBB
$455M
| $760K | ﹤0.01% |
44,132
+8,290
| +23% | +$135K |
|
3320
Funko
FNKO
$328M
| $759K | ﹤0.01% |
159,363
+22,709
| +17% | +$104K |
|
3321
Jakks Pacific
JAKK
$293M
| $756K | ﹤0.01% |
36,390
-3,812
| -9% | -$77.6K |
|
3322
iShares Currency Hedged MSCI Emerging Markets
HEEM
$282M
| $754K | ﹤0.01% |
25,102
-1,398
| -5% | -$39.6K |
|
3323
JPMorgan Diversified Return International Equity ETF
JPIN
$377M
| $752K | ﹤0.01% |
11,734
-615
| -5% | -$37.3K |
|
3324
Amplify Energy
AMPY
$166M
| $750K | ﹤0.01% |
234,305
+205,606
| +716% | +$611K |
|
3325
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$705M
| $749K | ﹤0.01% |
9,798
+787
| +9% | +$58.5K |
|
Similar funds
Ameriprise's Q2 2025 Portfolio in Review
As of Q2 2025, Ameriprise held 4,177 positions worth $406B, up 9.5% from $370B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Ameriprise's Q2 2025 filing shows 166 new, 1,840 increased, 1,831 reduced and 222 closed positions. Its largest new stake was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M. The largest sale was AbbVie, an estimated $581M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
- Ameriprise's largest Q2 2025 buy was JPMorgan Mortgage-Backed Securities ETF: 3,498,838 shares worth $176M.
- Ameriprise added most to Alphabet (Google) Class A in Q2 2025, an estimated $601M increase.
- Ameriprise's biggest Q2 2025 reduction was AbbVie, cutting an estimated $581M.
- Ameriprise fully exited Discover Financial Services in Q2 2025, selling an estimated $111M.
- Ameriprise's ten largest holdings make up 21% of its $406B portfolio in Q2 2025.
- Ameriprise opened 166 new positions and closed 222 in Q2 2025.
- Ameriprise's portfolio value rose 9.5% quarter-over-quarter to $406B.
Based on Ameriprise's 13F filing for Q2 2025, filed 14 Aug 2025.